| Financial Year |
March 31 2023 |
| Monetary Funds |
1,493,348,079.98 |
| Held-for-trading Financial Assets |
8,827,794.66 |
| Notes Receivable |
16,000,000.00 |
| Accounts Receivable |
23,115,269.78 |
| Advances to Suppliers |
97,424,750.16 |
| Other Receivables |
500,668,492.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
194,830,608.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,078,812.23 |
| Total Current Assets |
2,350,293,808.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
70,509,960.82 |
| Investment Properties |
600,376,973.03 |
| Fixed Assetes |
895,456,125.51 |
| Under-construction Projects |
181,896,092.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
441,077,198.79 |
| R&D expenses |
-- |
| Goodwill |
6,161,527.48 |
| Long-Term Deferred and Prepaid Expenses |
8,507,635.97 |
| Deferred Income Tax Assets |
4,521,968.67 |
| Other Non-Current Assets |
1,680,000.00 |
| Sub-Total of Non-Current Assets |
2,217,636,818.66 |
| Total Assets |
4,567,930,626.66 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
128,900,000.00 |
| Accounts Payable |
85,823,483.97 |
| Accounts Received In Advance |
30,377,534.46 |
| Employee Compensation Payable |
3,809,302.63 |
| Taxes Payable |
16,856,325.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
100,678,243.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
182,137,744.42 |
| Other Current Liabilities |
9,733,525.30 |
| Sub-Total of Current Liabilities |
648,699,624.02 |
| Long-term Loans |
373,272,868.62 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
923,240.04 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,419,052.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
584,777,929.35 |
| Total Liabilities |
1,233,477,553.37 |
| Paid-In Capital(Or Share Stock) |
738,148,117.00 |
| Capital Surplus |
1,694,435,050.71 |
| Surplus Reserve |
88,744,930.09 |
| LESS:Treasury Stock |
37,234,600.93 |
| Undistributed Profits |
579,988,731.80 |
| Minority Stockholder's Interest |
258,715,370.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,075,737,702.76 |
| Owner's Equity（Stockholder's Equity） |
3,334,453,073.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,567,930,626.66 |
